DV Trading’s Edwards Lifesciences EW Stock Holding History

DV Trading’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-700	Closed	-$59.7K	–	715
2025 Q4	$59.7K	Buy	+700	New	+$57.4K	﹤0.01%	401

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

DV Trading's EW Position: Q1 2026 in Review

DV Trading sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 700 shares — an estimated $59.7K sold.

DV Trading first reported a position in EW in Q4 2025 and held it in 1 quarter. The position peaked at $59.7K in Q4 2025. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

DV Trading reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
DV Trading sold 700 Edwards Lifesciences shares in Q1 2026, an estimated $59.7K.
DV Trading first reported a position in Edwards Lifesciences in Q4 2025 and held it in 1 quarter.
DV Trading's Edwards Lifesciences position peaked at $59.7K in Q4 2025.
1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on DV Trading's 13F filing for Q1 2026, filed 15 May 2026.